Development of a novel 3D bioprinting model to explore skeletal muscle energy metabolism in women with PCOS
Funding has been awarded to Dr McIlroy and Prof O’Reilly to develop a 3D bioprinting model to explore the impact of androgen excess on skeletal muscle energy metabolism in women with PCOS. New team member, Zahra Farahbakhsh, and Dr Leanne Cussen will be working with our industry partner, Inventia Life Sciences, to develop novel models of PCOS to improve our understanding of this complex disease and potentially help target patient treatment.
Recent News posts
![]()
NEW REVIEW: 11-Oxy Androgens in Human Health
A new review co-authored by Clinical Lead, Prof Michael O'Reilly alongside prominent biochemist, Prof Karl-Heinz Storbeck (Stellenbosch University,…
![]()
Research seminar series April 2023
Team member Stephanie Agabana MSc, will be presenting her research into androgens in endocrine resistant breast cancers at…
![]()
GRANTS UPDATE
RCSI Translational Seed Funding (October 2022) Project: ‘Utilising a 3D bioprinting model to dissect the impact of androgen excess…
![]()
RCSI Collaborate - Sex Steroids Meeting
We had a really successful meeting last week with a wonderful line-up of international and local speakers for…
